The global at-home drug of abuse market is growing at a significant rate, due to the mounting usage of illegal drugs among teenagers, and augmented manufacture and exchange of illicit drugs.

The different products such as a rapid drug of abuse test kits and breath analyzers contributed to the at-home drug of abuse market size.

Request for a free sample copy of this research report at https://www.vynzresearch.com/healthcare/at-home-drug-of-abuse-market/request-sample

Mounting dependence for synthetic cannabinoids, bath salts, and other evolving drugs are the trends in the at-home drug of abuse market.

Augmented manufacture and exchange of illegal drugs, technological advancement, programs by government organizations to decrease the intensity of drug abuse, and mounting usage of illicit drugs among teenagers are the primary growth drivers for an at-home drug of abuse market.

Mounting alertness about DOA testing, amplified usage of the drug of abuse tests for lawful and medical purposes, and alternative substance addiction are also facilitating the growth for the at-home drug of abuse market.

Browse full research report description at https://www.vynzresearch.com/healthcare/at-home-drug-of-abuse-market

North America is the largest at-home drug of abuse market as in the region the frequency of drug trafficking is increasing.

Key players in the at-home drug of abuse market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In August 2017, Psychemedics Corporation launched a synthetic cannabinoids test. UCP Biosciences Inc. Assure Tech Co. Ltd., Home Health Ltd., Orient New Life Medical Co. Ltd., Confirm BioSciences, Abbott Laboratories, and Psychemedics Corporation are the key players offering at-home drug of abuse.

Source: VynZ Research